Want to see USAQ full AI Analyst Report?
QHSLab (USAQ) Price & Analysis
USAQ Stock Chart & Stats
- Day’s Range
- $0.30 - $0.30
- 52-Week Range
- $0.16 - $1.14
- Previous Close
- $0.31
- Volume
- 1,059
- Average Volume (3M)
- 1,857
- Market Cap
- $4.51M
- Enterprise Value
- $5.89M
- Total Cash (Recent Filing)
- $317.39K
- Total Debt (Recent Filing)
- $95.55K
- Price to Earnings (P/E)
- 6.3
- Beta
- 1.29
- Next Earnings
- Apr 01, 2027
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Profitability Turnaround
Revenue has expanded from about $1.41 million in 2023 to $3.02 million on a TTM basis, while profitability has turned positive. The combination of strong gross margin and a 17% net margin indicates improving operating economics and provides a foundation for continued reinvestment.
Repaired Balance Sheet
Very low leverage and positive equity materially improve financial flexibility after earlier periods of negative equity. A less debt-dependent capital structure can reduce interest burden, support investment in growth, and improve the company’s ability to withstand operating volatility.
Recurring Software-Enabled ISP Growth
The shift toward a recurring, software-enabled Integrated Service Program strengthens the business model beyond one-time revenue sources. Rapid ISP growth and deeper provider relationships could improve revenue visibility, customer retention, and gross-margin durability as adoption expands.
Bears Say
Negative Cash Conversion
Negative operating and free cash flow show that reported earnings are not currently converting into cash, weakening earnings quality and financial flexibility. If this persists, QHSLab may have less internally generated funding for product development, sales investment, and ongoing obligations.
Inconsistent Operating Profitability
Although the latest period is profitable, fluctuating EBIT and EBITDA margins indicate that the cost structure has not yet demonstrated consistent operating leverage. This creates uncertainty about how reliably current earnings can be sustained as revenue growth changes or investment requirements increase.
Volatile Capital Structure History
The recent balance-sheet repair is meaningful, but prior negative equity and distorted leverage measures reveal a history of financial instability. That record raises the risk that future operating setbacks could again pressure capital adequacy and constrain strategic or growth investments.
QHSLab News
USAQ FAQ
What was QHSLab’s price range in the past 12 months?
What is QHSLab’s market cap?
When is QHSLab’s upcoming earnings report date?
How were QHSLab’s earnings last quarter?
Is QHSLab overvalued?
Does QHSLab pay dividends?
What is QHSLab’s EPS estimate?
How many shares outstanding does QHSLab have?
What happened to QHSLab’s price movement after its last earnings report?
Which hedge fund is a major shareholder of QHSLab?
What is the TipRanks Smart Score and how is it calculated?
Company Description
QHSLab
QHSLab, Inc. is a company operating in the medical technology and Software-as-a-Service (SaaS) sectors. Its core focus is on advancing value-based healthcare, medical informatics, and personalized medicine driven by algorithms. The firm also develops digital therapeutic solutions and on-site technologies intended for remote patient oversight, the management of chronic conditions, and proactive health maintenance. Among its offerings is a proprietary cloud-based SaaS platform, also known as QHSLab (Quality Health Score Lab expert system). This system empowers physicians and healthcare organizations to securely record and store electronic patient data. Additionally, QHSLab, Inc. acts as a distributor, providing primary care physicians with AllergiEnd, a product line encompassing diagnostic tools and allergen immunotherapy treatments. All of its solutions are strategically designed to aid in the prevention, early identification, effective management, and potential reversal of chronic diseases. The company was established in 1983 and is headquartered in West Palm Beach, Florida. It operated under the name USA Equities Corp. until April 2022, when it officially rebranded to QHSLab, Inc. The company also maintains a strategic partnership with Medical License Factory, LLC.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Troy James Grogan
- Employees
- 12
- Website
- www.qhslab.com
- Address
- 901 Northpoint Parkway, West Palm Beach, FL, 33407, US
QHSLab (USAQ) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 3 | 15 |
| Technical Analysis | 4 | 3 | 3 |
| Moving Averages | 0 | 0 | 12 |






